Ajay Goel
Beckman Research Institute, City of Hope Comprehensive Cancer Center
Appearances
- DateMay 6, 2023The epigenome is the heritable portion of the genome that is mediated by chemical modification of DNA (methylation) or nuclear proteins (histones, transcription factors) without changing the DNA sequence…
Moderators
University of MichiganBeckman Research Institute, City of Hope Comprehensive Cancer Center - DateMay 8, 2023BACKGROUND: Alcohol-associated hepatitis (AH) is the active inflammatory state of alcohol-associated liver disease (ALD). AH varies in severity from mild to severe with mortality rates reaching 30-50% in severe AH…
Presenter
Speakers
Beckman Research Institute, City of Hope Comprehensive Cancer Center - DateMay 18, 2024
Presenter
Beckman Research Institute, City of Hope Comprehensive Cancer Center - DateMay 18, 2024Background: Esophageal cancer incidence and mortality are projected to increase by 58.4% and 61.8% by the end of 2040, making esophageal squamous cell carcinoma (ESCC) – the most common subtype a significant public health threat…
Presenter
Speakers
Beckman Research Institute, City of Hope Comprehensive Cancer Center - DateMay 21, 2024SOCIETY: AGA Aging is associated with increased GI cancer risk but the mechanisms underlying these age related effects are incompletely understood. Better understanding of mechanisms of aging and GI carcinogenesis will enable new approaches to early detection and prevention…
Moderators
Northwestern UniversityBeckman Research Institute, City of Hope Comprehensive Cancer Center - DateMay 21, 2024Background: Tumor recurrence is the event that has a major impact on survival after local resection of submucosal colorectal cancers (T1 CRC). However, currently, there are no established biomarkers to predict disease-free survival (DFS) in T1 CRC…
Presenter
Speakers
Beckman Research Institute, City of Hope Comprehensive Cancer Center - DateMay 21, 2024INTRODUCTION: Patients with early-onset colorectal cancer (EOCRC), defined as diagnosed before age 50, have a significant risk of metachronous CRC after curative resection. The practice of offering intensive endoscopic surveillance, although often used, has not been formally validated…
Presenter
Speakers
UCSD School of MedicineBeckman Research Institute, City of Hope Comprehensive Cancer Center - DateMay 18, 2024SOCIETY: AGA Join this session to review current and future applications for AI in assessing GI cancer risk, and guiding cancer screening and cancer therapeutics in research and clinical care settings…
Moderators
Columbia University Medical CenterUniversity of Michigan Medical CenterSpeakers
Beckman Research Institute, City of Hope Comprehensive Cancer CenterJohns Hopkins Hospital - DateMay 3, 2025Uncover the genetic and molecular foundations of GI disorders to drive precision medicine and innovative therapies…
Moderators
Beckman Research Institute, City of Hope Comprehensive Cancer CenterUCLA